Enterprises to do drugs to attract investment to do a good job in the regional market can be called "king"

The price promotion of drug product promotion channel for brand products must be carried out step by step, plan, and step by step, and the key points of each measure must be designed, the orderly connection between each link should be completed, and the first-tier quotient of each regional market must be determined. And its corresponding secondary distributors as an agreement sales unit, so that they enjoy the agreement sales prices and services. The primary criteria for screening primary quotients are: The regional market's mainstream pharmaceutical logistics distribution companies, whose distribution can effectively solve the regional market product coverage requirements, while pharmaceutical investment enterprises must also have better financial strength and warehousing capabilities.

First of all, the pharmaceutical investment website points out that the focus of the commercial work of the pharmaceutical investment market is on the management of secondary commerce, and secondary commerce should be ordered and merged into the designated tier-1 commercial channel to facilitate the management of the directional channel flow chain. The secondary tier is mainly responsible for the terminal distribution of the products. The core of management lies in the orderly planning of the terminal coverage area and encourages distributors to orderly cover the market terminals. The mainstream chain drugstores in the regional drug investment market can be positioned as secondary distributors in the region, and they can conduct management by merging and designating the first-level merchants to facilitate the smooth development of related work.

Secondly, the introduction of the drug investment website describes the understanding of the business concept of the first-tier merchants, especially the management and control ideas for the prices of drug investment enterprises, and must be able to maintain a high degree of consistency with the upstream industries, and have a strong sense of cooperation and provide related resources and management. The capabilities, such as monitoring the inventory and delivery of specialized varieties, and tracking the flow of warehouse shipments, should be determined based on the market coverage of the target area. Repeated coverage of different commercial channels in the same area should not exceed 40%.

Finally, it is necessary to effectively do a good job of ideological education for grass-roots employees in the regional market to ensure that the price-enhancing work can be implemented in all aspects without compromise. In order to support price-fixing work, a high degree of unanimity must be reached within the drug investment enterprise, especially the middle and senior managers of the company and the person in charge of each regional market. The recognition must be highly unified. Pharmaceutical investment enterprises must be highly ideologically recognized and support price-fixing work, have the determination and confidence to completely rectify the current market conditions, and be able to accurately grasp the balance between current sales volume and future development.